AzTrials
AzTrials

Completely Edentulous MaxillaNCT06011031

Assessment of Novaloc and Locator Attachment Systems

A study testing Novaloc attachment and Locator attachment in people with Completely Edentulous Maxilla, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the current study is to assess the effect of two types of attachments (Locator, Novaloc) on the supporting structures both mechanically using stress strain analysis and biologically through measuring bone height using cbct. Read more about this study

Who is it for?
Ages 30 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Completely Edentulous Maxilla
What is being tested?
Novaloc attachment and Locator attachment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteEgypt
Study dates
5 Jun 2021to 5 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Completely edentulous patient with u shaped dental arch.
  • Systemically free.
  • Patients completed all extraction at least 6 months before surgery.
  • Patients Tempromandibular joint is free from any disease.
  • Patient's mouth opening is proper for accessibility during surgery and implant placement.
  • Sufficient bone level (length, and width) at implant placement site.
  • Presence of enough bone height at implant site close to the maxillary sinus.
  • Absence of sinus pneumatization.

Who cannot join

  • Heavy smoker.
  • Patients with bone diseases.
  • Patients having a history of parafunctional habits.
  • Patients with diabetes mellitus.
  • Patients on chemotherapy or radiotherapy.
  • Patients on any medications that reduce wound healing.
  • Patients without sufficient bone level (height, width).
  • Patients with sinus pneumatization.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Prosthodontics Department Faculty of Dentistry Ain Shams University

    Cairo, 11591

Other trials in Egypt

About this study

Official title: Mechanical and Biological Assessment of Two Different Attachment Materials in Maxillary Implant Retained Overdenture In-Vivo Study

The aim of the current study is to assess the effect of two types of attachments (Locator, Novaloc) on the supporting structures both mechanically using stress strain analysis and biologically through measuring bone height using cbct.

Read the detailed description

14 Completely edentulous patients will be divided into two groups each group contains seven patients: Group One: Each patient will be restored with 4 implant retained maxillary overdenture using Peek retention inserts attachment system and Bone Level Ti-Zr implants.

Group Two: Each patient will be restored with 4 implant retained maxillary overdenture using Nylon retention insert attachment system and Bone Level Ti implants.

Bone height in millimeters will then be evaluated around each implant using cone beam computed tomography at the time of placement of attachments, 6 months, 1 year

Being tested
Novaloc attachment, Locator attachment
Keywords
implant overdenture, maxilla, novaloc, locator, peek

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Novaloc attachmentDevice

    Each patient will be restored with 4 implants retained maxillary overdenture with the assigned attachment

  • Locator attachmentDevice

    Each patient will be restored with 4 implants retained maxillary overdenture with the assigned attachment

Study groups in NCT06011031
Study groupRoleWhat they receive
Novaloc attachmentExperimentala newly developed device "novaloc attachment system"made of peek material and amorphous diamond like carbon.
Receives: Device: Novaloc attachment
locator attachmentActive comparatora device with low-profile attachment used in cases of limited inter arch distance, provides excellent retention, possesses a self-aligning property and allow correction of implant divergence up to 20 degrees
Receives: Device: Locator attachment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone level change around implants

    measurement of bone height mesial, distal to each implant

    Measured: Through study completion an average 1 year.

Secondary outcomes (1)
  1. patient satisfaction

    Patient satisfaction was evaluated using a questionnaire based on the visual analog scale (VAS). Patients were asked to mark their answers (amount of satisfaction). The questionnaire was given to the patients in Arabic.Six factors were rated on a 1 to 5 scale (highly satisfied = 5; satisfied = 4; fair = 3; dissatisfied = 2; highly dissatisfied = 1). The sum of the five sub-scores was then calculated, ranging from 5 to 30 (best score = 30, worst score = 5). The low range of scores indicated low satisfaction.

    Measured: Through study completion an average 1 year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2023
  2. Study start5 Jun 2021
  3. Primary completion5 Dec 2024 (estimated)
  4. Study completion5 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a Randomized Clinical Trial (phase IV) as it will compare two types of attachment systems (a new one with an old one), assess the effects of both types, and state which one is better.
Masking
Single blind
Who is masked
Investigator
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06011031
Sponsor's protocol ID
FDASU- Rec ID 032117
Status last verified
Jul 2023
First submitted
21 Jul 2023
Last updated
1 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: once all data is collected, sharing of Study Protocol,Statistical Analysis Plan (SAP),Clinical Study Report (CSR) will be done

Questions about this trial

What is this clinical trial studying?

A study testing Novaloc attachment and Locator attachment in people with Completely Edentulous Maxilla, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone level change around implants (time frame: Through study completion an average 1 year.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in